GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized ...
A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are actually safe and ...
The US Food and Drug Administration (FDA) has called on its Pharmacy Compounding Advisory Committee to discuss whether a ...
Federal health officials will meet in July to weigh easing limits on a group of drugs popular with Robert F. Kennedy Jr.'s ...
The agency’s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. Kennedy Jr. told ...
NEW YORK – BioCardia on Thursday said it plans to meet with the US Food and Drug Administration to discuss whether it can seek accelerated approval for its autologous cell therapy CardiAMP. Sunnyvale, ...
Guide highlights key compliance scenarios—from FDA actions to global expansion—where consulting is essential. IRVINE, CA, UNITED STATES, April 1, 2026 ...
Eli Lilly’s once-daily pill for weight loss got approval from U.S. drug regulators Wednesday. The all-clear sets up a battle with rival Novo Nordisk, which has been selling a pill version of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results